A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: disintegrate (1), crumble (10), collapse (38)

Annual-report-and-quality-account-2019-20

Description
ANNUAL REPORT AND ACCOUNTS 2019/20 Incorporating the quality account 2019/20 Page 2 University Hospital South
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-and-quality-account-2019-202.pdf

Apalutamide v1

Description
Chemotherapy Protocol PROSTATE APALUTAMIDE Regimen  Prostate cancer Indication  Apalutamide is recommended
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Apalutamide-v1.pdf

Peptide receptor radionuclide therapy (PRRT) - patient information

Description
This factsheet explains what peptide receptor radionuclide therapy (PRRT) is, what the therapy involves, and what the possible benefits and risks
Url
/Media/UHS-website-2019/Patientinformation/Scansandx-rays/Peptide-receptor-radionuclide-therapy-PRRT-3016-PIL.pdf

Papers Trust Board - 11 March 2025

Description
Date Time Location Chair Agenda Trust Board – Open Session 11/03/2025 9:00 - 13:00 Conference Room, Heartbeat Educa
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-11-March-2025.pdf

Health and safety policy

Description
Health and Safety Policy Date Issued: 21/11/18 Review Date: 21/11/21 Document Type: Policy Version: 10.0 Contents Paragraph 1 2 3 4 5 6 7 8 9 Appendi
Url
/Media/UHS-website-2019/Docs/Policies/Health-and-safety-policy.pdf

IdelalisibRituximab

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia (CLL) Idelalisib-Rituximab Regimen • CLL – Idelalisib-Rituximab Indication • Chronic lymphocytic le
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/IdelalisibRituximab.pdf

Appendix B - VZIG risk assessment and prescription form

Description
Varicella zoster Immunoglobulin for post-exposure prophylaxis (PEP)Please note that UHS Pharmacy will issue VZIG only when both RISK ASSESSMENT and PRESC
Url
/Media/UHS-website-2019/Docs/Post-Exposure-Prophylaxis-Policy/AppendixB-VZIGRiskAssessmentandPrescriptionForm.pdf

Papers Trust Board - 27 July 2023

Description
Date Time Location Chair Agenda Trust Board – Open Session 27/07/2023 9:00 - 13:15 Conference Room, Heartbeat/Microsoft Teams
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2023-Trust-documents/Papers-Trust-Board-27-July-2023.pdf

Finance and Performance Reports 2020-21 Month 4 July 2020

Description
2020/21 Finance Report - Month 4 Report to: Board of Directors and Finance & Investment Committee August 2020 Title: Finance Repor
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2020/finance-and-performance-reports-2020-21-month-4-july-2020-1.pdf

Papers Sept 2020 held in closed session due to Covid-19

Description
Date Time Location Chair Agenda - Trust Board Meeting 29/09/2020 9:00 - 16:00 Microsoft Teams Peter Hollins 1 Chair’s Welcome, Apologies and Declarations
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2020/papers-sept-2020-held-in-closed-session-due-to-covid-19.pdf
21 to 30 of 39
Previous 1 2 3 4 Next